Background. Volatile anesthetics are used to provide anesthesia to patients with heart disease under heightened adrenergic drive. The purpose of this study was to test whether volatile anesthetics can inhibit norepinephrine (NE)-induced apoptosis in cardiomyocytes.
APOPTOSIS, the genetically programmed cell death, is executed by an energy-dependent and cell-inherent suicide machinery that requires de novo gene expression and leads to destruction and removal of cells that are no longer needed or damaged. Recent observations have indicated that apoptotic cardiomyocyte cell death plays a key role in the deterioration of myocardial function in a variety of pathologic situations. Programmed cell death has been reported to occur in myocardial infarction,' heart failure,* and toxic, inflammatory, and endocrine cardiomyopathies. Furthermore, experimental induction of cardiac apoptosis has been achieved by pressure overload,3 tachycardia,* and left ventricular hypertr~phy,~ as well as by several endogenously released excitotoxic factors, including tumor necrosis factor-a,' atrial natriuretic peptide,' angiotensin 11,8 and norepinephrine Catecholamines, although beneficial in short-term cardiovascular response, exert significant cardiac toxicity. '' Enhanced activation of P-adrenergic signaling results in necrotic' as well as apoptotic' cardiomyocyte death. Accordingly, acute accumulation of endogenously released catecholamines was reported to accelerate ischemic cardiomyocyte damage, l 2 and chronic sympathetic nervous activation was related to progressive cell death in heart fai1~re.l~ Volatile anesthetics are frequently used to provide general anesthesia to patients with significant heart disease under conditions of heightened adrenergic drive, a hallmark of the perioperative neuroendocrine stress response.'* Although volatile anesthetics are known to exert significant cardioprotection after ischemia and reperf~sion,'~-'' it is not clear, to date, whether volatile anesthetics modulate the cell suicide program evoked by catecholamines. The purpose of this study was to determine whether exposure to volatile anesthetics affects NE-induced apoptosis in adult cardiomyocytes in vitro and, if so, to investigate the cellular mechanisms involved.
Materials and Methods

Myocyte Cultures and Cell Treatments
The investigation conformed to the American Physiological Society's rules for the care and use of laboratory animals. Protocols were approved by the Institutional Animal Care and Use Committee. CaZf-tolerant adult rat ventricular myocytes were isolated from hearts of male Sprague-Dawley rats (300 -350 g), essentially as previously described. l8 Twenty minutes before decapitation, animals were heparinized (500 U intraperitoneally). The hearts were quickly removed into an ice-cold HEPESbuffered solution (117 m M NaCl, 5.7 m M KCI, 1.5 flul NaH,P04, 4.4 m M NaHCO,, 20 m M HEPES, 10 m M glucose, 10 m M creatine, at pH 7.4) containing 1.8 m M Ca2+ and retrograde-perfused on a Langendorff apparatus for 5 min at 37°C gassed with oxygen. The perfusion solution was switched to a nominally Ca2+-free solution containing 0.1 m EGTA for 7 min and then to a nominally Ca2+-free solution containing 0.15% collagenase B (Boehringer Mannheim, Indianapolis, IN). After 30 min of digestion, the enzymatic solution was washed out and the tissue from the left ventricle was cut into small pieces and gently swirled in the HEPES-buffered solution containing 0.125 m CaZf. Dissociated cells were filtered through a 200-pm mesh and allowed to settle for 20 min. The cells were then resuspended in the buffered solution containing 5 mg/ml bovine serum albumin and exposed to a graded series of increasing Ca2+ concen-trations up to 1.8 m. Each step was followed by a gentle centrifugation with less than 20 g for 2 min to separate the ventricular myocytes from nonmyocytes. The isolated myocytes were resuspended in serum-free defined culture medium consisting of Dulbecco's modified Eagle medium with 2 mg/ml bovine serum albumin, 2 rn L-carnitine, 5 m M creatine, and 5 nm taurine supplemented with 100 U/ml penicillin, 100 pg/ml streptomycin, and 0.25 pg/ml amphothericin B. They were cultured at a density of 100 -150 cells/mm2 in 60-mm plastic culture dishes (Falcon, Cockeysville, MD) or on 22-X 22-mm glass coverslips (Fisher, Pittsburgh, PA) precoated with laminin (1 pg/cm2, Sigma, St. Louis, MO) placed in 35-mm plastic culture dishes. After 3 h, the dishes were washed to remove cells that were not attached. Purity of myocyte cultures was assessed by determining the percentage of myosin-positive staining cells after attachment on glass coverslips using immunofluorescence with a myosin heavy chain-specific antibody, MF-20.19 Cell viability was assessed by counting the number of adherent cells on 35-mm dishes 3 h after plating as well as at the end of the experiments. Briefly, cells were washed with Dulbecco's modified Eagle medium, and five randomly chosen fields (1 mmZ) were counted at 10 X 10 magnification with a phase-contrast microscope (Leitz, Germany) in duplicate dishes. In addition, percentages of rounded cells as well as quiescent rod-shaped cells were scored.
The treatment protocols and the concentrations of the reagents used were established previously.' In the various protocols, for each experimental group, cells of 10 different rat hearts were used, and all experiments were performed in duplicate or triplicate dishes. 1-NE (10 p~; Sigma) was added to culture dishes for 3,6, 12, and 24 h, respectively. AU dishes were supplemented with fresh ascorbic acid (0.1 mM; Sigma). A multiple gas-mixing incubator (Newage Industries, Willow Grove, PA) was used to administer volatile anesthetics to cell cultures for 3, 6, 12, and 24 h, respectively, by placing the agentspecific vaporizer (isoflurane: Airco, Madison, WI; halothane: Draeger, Lubeck, Germany) between the adjustable fresh gas supply and the interior of the incubator. A stable interior chamber atmosphere with 21% 0,, 5% CO,, and the required anesthetic concentrations was obtained within 5 min of equilibration at 37°C. A Datex infrared gas analyzer (Puritan-Bennett, Tewksbury, MA) continuously controlled the delivered vapor concentrations of the volatile anesthetics in the incubator. To assess the NE-induced apoptosis dose-response to isoflurane and halothane, in some experiments cells were exposed to increasing concentrations of isoflurane (Marsam Pharmaceuticals, Cherry Hill, NJ) (0.7%, 1 
Terminal Deoxynucleotidyl Transferase-mediated Nick End Labeling Assay
Nick-end labeling was performed in cells plated on glass coverslips using the CardioTACS in situ Apoptosis Detection kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. A positive control was generated by using TACS-nuclease working solution containing DNase I. For each staining procedure, control myocytes were treated with DNase and used as positive control. The cells were incubated with terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) mixture (terminal deoxynucleotidyl transferase and biotinylated nucleotides) for 1 h at 37°C in a humidified chamber. Apoptotic nuclei were visualized with a streptavidinconjugated horseradish peroxidase followed by TACS Blue label and Red counterstain C. The percentage of TUNELpositive staining cells was determined by counting positive nuclei at 10 X 10 magnification in five randomly chosen fields (1 mm2) in duplicate or triplicate plates using light microscopy.
AnnexinV Staining
AnnexinV-fluorescein isothiocyanate conjugated (FITC)/ propidium iodide staining was performed using an Annex-inV-Fluos Staining kit (Boehringer Mannheim). Briefly, cells plated on coverslips were washed with phosphatebuffered saline and then incubated for 10 min in 100 p1 staining solution at room temperature and analyzed by fluorescence microscopy. FITC-labeled annexinV detects phosphatidylserine translocated from the inner to the outer cell surface, a hallmark of early apoptosis. Cells in late apoptosis or necrosis show additional positive nuclear staining with propidium iodide and are indistinguishable from each other.20 The percentage of early apoptotic cells with only green sarcolemmal staining (annexinv-FITC excited at 450-480 nm) and of late apoptotic and necrotic cells with both green sarcolem-ma1 staining and red nuclear staining (propidium iodide excited at 510-550 nm) was determined at 10 X 10 magnification in five randomly chosen fields in duplicate dishes (1 mm2).
Analysis of Genomic DNA (DNA Laddering)
Internucleosomal DNA fragmentation was assessed using an isotopic TACS Apoptotic DNA laddering kit (R&D Systems). DNA samples (1 pg) from control and experimental cultures were labeled by enzymatic assay with terminal deoxynucleotidyl transferase in a buffer containing 0.5 pCi [32P]dCTP (New England Nuclear, Beverly, MA). After incubation for 10 min at room temperature, the reaction was stopped by adding 2 pl gel loading buffer, and the samples were analyzed on a 1.5% agarose gel at 100 V using TAE (tris base-acetic acid-EDTA) buffer. The gel was fixed in 10% acetic acid, dried, and exposed to x-ray films. Labeled 1-kb DNA ladder was used as marker. Photographic images were obtained, digitized, and quantified using SigmaGel (Jandel, Chicago, IL).
Determination of the Enzymatic Activities of the Upstream Caspase-8 and -9
Determination of caspase-8 and -9 enzymatic activities was performed using Caspase-8 and -9 Colorimetric Assay kits (R&D Systems). Briefly, cells were washed with phosphate-buffered saline, counted, trypsinized, and resuspended in lysis solution. Caspase-8 and -9 -specific substrates conjugated to the color reporter molecule p-nitroanilide were added to the cell lysates. After 2 h of incubation at 37"C, p-nitroanilide was quantitated spectrophotometrically at a wavelength of 405 nm in duplicate dishes (Microplate Reader Model EL 308; BIO-TEK, Burlington, VT). After correcting for background activity and number of cells, enzyme activity was expressed as percent increase in activity over control cells.
Transmission Electron Microscopy
A separate set of experiments was performed on laminin-coated permeable membrane filters (Costar, Carnbridge, MA). Monolayers were fixed with 3% glutaraldehyde in 0.1 M cacodylate buffer at pH 7.3 and postfixed with 1% osmium tetroxide in the cacodylate buffer for 1 h at 4°C. Samples were dehydrated through ethanol and infiltrated with LR White embedding resin (London Resin Company, Berkshire, England), which was then allowed to polymerize in a 6 0 T oven for 72 h. Thick longitudinal sections were cut at 1 pm, stained with methylene blue, and examined by light microscopy. Thin sections (50 nm) were then prepared from selected areas and stained with uranyl acetate and lead citrate. JEM-1OOC OEOL, Tokyo, Japan) was used for electron microscopy.
Statistical Analysis
Data are expressed as mean 2 SD. Student unpaired t test was used to compare control with NE-treated cells.
Analysis of variance with post hoc Scheffe test for multiple comparisons was performed to determine statistical significance of multiple treatments. P < 0.05 was considered significant (StatView Software, Abacus Concepts, Berkeley, CA).
Results
Norepinephrine-induced Apoptosis
More than 99% of cells stained positively with the MF-20 antibody, indicating an essentially pure cardioniyocyte population. The few irregular contractions present immediately after cell isolation nearly disappeared completely after attachment. During the course of the experiments, the majority of myocytes remained viable and attached to culture dishes in control cultures over a 24-h period (85 ? 6% of baseline, n = 10 in duplicates). Administration of NE significantly decreased the number of adherent cells to 76 2 4%, 70 t 4%, and 65 5 6% of baseline after 6, 12, and 24 h, respectively, of NE exposure (P < 0.001 us time control, n = 10 in duplicates).
In addition, after 6, 12, and 24 h, in control cultures the majority of myocytes retained their distinctive cylindrical shape, with only 2 f 2%, 3 t 2%, and 4 f 4% of adherent cells, respectively, showing a rounded morphology and disorientation of cross-striations. However, these morphologic changes occurred in 60 2 8%, 75 -+ 6%, and 
Volatile Anesthetics Decrease Norepinephrineinduced Apoptosis
Isoflurane and halothane dose-dependently inhibited NE-induced apoptosis, as assessed by TUNEL staining (n = 10 in triplicates; fig. 1B ). Isoflurane at 0.4 MAC and halothane at 0.3 MAC markedly inhibited NE-induced apoptosis (P < 0.001 us NE), whereas isoflurane at 1.6 MAC and halothane at 1.2 MAC completely blocked apoptotic cell death when compared with control plates. The majority of rounded cells and also some with cylindrical shape showed positive TUNEL reaction (figs. 2A-E). Optimal concentrations of volatile anesthetics (isoflurane at 1.6 MAC and halothane at 1.2 MAC) and the optimal time interval of 12 h were chosen in all subsequent experiments to facilitate exploration and delineation of the apoptotic response between the various experimental groups.
The percentages of adherent myocytes exhibiting the early apoptotic pattern of annexinV/propidium iodide labeling (positive sarcolemmal staining with annexinV but no nuclear staining with propidium iodide: An+/ PI-) as well as the late apoptotic (or necrotic) pattern of labeling (positive sarcolemmal staining with annexinV and concomitant nuclear staining with propidium iodide: An+/P+) were significantly increased in NEtreated dishes (An+/pI-: 28 t 4%; An+/FI+: 10 t 3%) when compared with control dishes (An+/PI-: 3 -f 2%; An+/PI+: 2 t 2%; P < 0.0001, n = 10 in duplicates).
Similarly to diltiazem and propranolol, isoflurane at 1.6 MAC and halothane at 1.2 MAC reduced the percentages of single-and double-staining adherent cells to levels observed in control dishes (figs. 3A-C).
The isolated DNA, which was size-fractionated by electrophoresis, exhibited a typical DNA ladder pattern. Clearly increased intensity of low molecular DNA fragments (180-1,000 base pairs) was observed in DNA from myocytes treated with NE (P < 0.0001 us control). Similarly to diltiazem and propranolol, isoflurane at 1.6 MAC and halothane at 1.2 MAC reduced the quantity of fragmented DNA to control levels as assessed by densitometry (n = 10 in duplicates; fig. 4 ). Diltiazem, propranolol, and the volatile anesthetics alone did not affect the quantity of apoptosis as assessed by TUNEL staining, annexinV/propidium iodide staining, and DNA laddering when compared with control dishes. 6 . Modulation of the apoptotic response by the Caz+-channel activator BAY K-8644 and the Caz+-ionophore 4bromo-A23187. Myocytes were exposed to BAY K-8644 (1 p~) or 4-bromo-A23187 (1 p~) in the presence or absence of norepinephrine (NE; 10 p~) and/or halothane (HAL; 1.2 MAC). HAL effectively decreased the percentages of myocytes undergoing Ca2+ channel activator-and Ca'+-ionophor+mediated apoptosis. Data are mean f SD. *P < 0.0001 versus control, t P < 0.05 versus respective treatment without the protective effects of halothane.
Mechanisms of Apoptotic Curdioprotection
Additional experiments with halothane at 1.2 MAC were performed to explore the mechanisms underlying the apoptotic cardioprotection by volatile anesthetics (n = 10 in duplicates; fig. 6 ). Myocytes were exposed to the dihydropyridine Ca'+-channel agonist BAY K-8644 and the Ca'+-ionophore 4-bromo-A23 187 in the presence and absence of halothane and/or NE. TUNEL-positive staining cells were evaluated after 12 h of exposure. Although treatment with the Ca'+-channel activator was more effective in increasing the percentage of TUNELpositive cells (34 * 4%) when compared with treatment with the Ca'+-ionophore 4brornc~A23187 (13 ? 4%; P < O.OOOl), both treatments signtficantly increased the percentage of TUNEL-positive staining cells (BAY K-8644 us control, P < 0.0001; 4-bromo-A23187 us control, P < 0.001). Furthermore, addition of NE potentiated the apoptotic response (BAY K-8644: 34 +-6% us BAY K-8644 + NE: 90 ? 5%, P < 0.0001; 4bromo-A23187: 13 f 4% us 4-bromo-A23187 + NE: 42 i 4'36, P < 0.0001). Conversely, halothane effectively decreased the percentage of apoptotic cells in Ca'+-channel activator-mediated apoptosis as well as in Ca2+-ionophore-mediated apoptosis (BAY K-8644 + halothane: 3 ? 2% us BAY K-8644: 34 +-6%, P < 0.0001; 4bromo-A23187 + halothane: 2 ? 1% us 4bromo-A23187: 13 ? 4%, P = 0.03). This protective effect continued to exist with concomitant NE treatment ( fig. 5) .
Norepinephrine treatment increased caspase-9 activity by 197 2 62% when compared with control cells (P < 0.0001, n = 10 in duplicates; fig. 7A ). Similarly to diltiazem and propranolol, isoflurane at 1.6 MAC and halothane at 1.2 MAC decreased caspase-9 activity to levels not significantly different from control. No significant increase in caspase-8 activity over control dishes was detectable in any of the treatment regimens (n = 10 in duplicates; fig. 7B ). ZAUGG €7-AL.
NE
Discussion
The major new finding of this study is that isoflurane and halothane dose-dependently decreased NE-induced apoptotic cell death in adult rat cardiomyocytes. The potency of volatile anesthetics in inhibiting apoptotic cell death was mimicked by the P-adrenergic receptor antagonist propranolol and the voltage-dependent Ca*+channel blocker diltiazem, and paralleled modulation of free intracellular Ca2+ concentration by the dihydropyridine Ca*+-channel activator BAY K-8644. However, the anti-apoptotic effect was preserved under the treatment with the Ca2+-ionophore 4-bromo-A23 187, which indicates that mechanisms other than depression of Ca2' influx through L-type Ca*+-channels may also have a role in the apoptotic protection by volatile anesthetics. The results of this study also demonstrate that caspase-9, a specific cysteine protease, is activated during NE-induced apoptosis, and that caspase-9 activation is effectively inhibited by volatile anesthetics. In contrast to necrosis, apoptosis is a strictly regulated and ordered removal of damaged cells with near-to-intact plasma membrane and virtually no inflammatory response. Cardiomyocyte apoptosis represents the major form of myocardial damage, significantly contributing to infarct size in rats,*l and constitutes a pivotal event in a variety of pathologic circumstances, including heart failure* and various forms of cardiomyopathies. Recent observations from cardiomyocytes in vitro emphasize the apoptogenic potential of several endogenously released factors, including tumor necrosis factor-a,6 atrial natriuretic peptide,' angiotensin 11,8 and NE.9 Although cardiotoxic effects of catecholamines have been known for many years, their toxicity was not related to enhanced P-adrenergic signaling until lately by Mann et al. lo Apoptotic cardiomyocyte death by activation of the P-adrenergic pathway was reported in NE-stimulated adult rat cardiomyoctes' and in isoproterenol-treated rat hearts2* Enhanced activation of the Padrenergic signaling by overexpression of Gsa in hearts of transgenic mice was also found to induce apopt~sis.*~ Furthermore, deleterious effects of endogenously released catecholamines during ischemia are well established'* and may trigger apoptosis. Accordingly, decreased apoptosis has been reported in carvedilol-and propranolol-pretreated rabbit hearts subjected to ischemia/reperfusion injury.**
The results of this study now demonstrate that NEstimulated apoptosis is dose-dependently inhibited in adult rat ventricular myocytes exposed to volatile anesthetics. Hallmarks of apoptotic events were assessed on various apoptotic execution sites, including the sarcolemmal, enzymatic, and nuclear level, and the results were internally consistent. Importantly, even lower concentrations of isoflurane and halothane, i.e., less than 1 MAC in rats and humans, effectively decrease NE-induced apoptotic cell death. Because the number of apoptotic cardiomyocytes was increased after only 6 h of NE exposure, the observed apoptotic cardioprotection by volatile anesthetics may be clinically relevant under intm operative conditions of heightened adrenergic drive, particularly in patients with preexisting heart disease.
Apoptosis involves a commitment phase followed by an execution phase.25 Numerous studies have implicated increases in intracellular free Ca2+ in apoptotic cell death.26 P-Adrenergic receptor stimulation leads to protein kinase A-mediated phosphorylation of L-type Ca2+ channels, thereby increasing the mean open time of single channels and the number of channels available for voltage-dependent activation.*' Massive cytosolic Ca2+ elevations subsequently trigger an increase in mitochondrkal membrane permeability, which is followed by liberation of holocytochrome c and apoptosis-inducing factor into the cytosol.28 These factors finally activate caspases, the executioners of apoptotic cell death. 25 Caspases cleave critical cellular substrates, including lamin and fodrin, precipitating the dramatic morphologic changes of apoptosis. Not all models of apoptotic cell death use the same caspases. Caspase-9, which is highly expressed in heart tissue,29 is an upstream initiator caspase directly activated by apoptogenic mitochondrial factors. The findings of this study confirm the pivotal role of increased intracellular Ca*+ on apoptosis and extend the previous observations by showing that NE initiates the apoptotic cascade by activation of caspase-9 in cardiomyocytes. Interestingly, caspase-8, the other major initiator ca~pase,~' was not activated in NE-treated cultures.
Volatile anesthetics are potent cardiodepressant agents" with favorable cardioprotective effects. l 5 -I 7 Volatile anesthetics affect hydrophobic sites in cell membranes, protein-protein and lipid-protein interactions. At a cellular level, volatile anesthetics efficiently change intracellular Ca2+ homeostasis by blocking sarcolemmal Ca2+ entry, inhibiting the Na+-Ca*+ exchange channel, and decreasing the Ca2+ content in the sarcoplasmic r e t i c~l u m .~~,~~ Because changes in CaZ* homeostasis play a pivotal role in events associated with myocardial injury,34335 changes in cellular Ca2' homeostasis by volatile anesthetics may explain, in part, the observed anti-apop totic effect. However, the anti-apoptotic effect of halothane was also present in L-type Ca2+ channel-independent a p optosis stimulated by the Ca2+ ionophore 4bromo-A23187. Thus, mechanisms other than pure inhibition in slow Ca2+ inward current through L-type Ca2+channels may be involved. These may incIude increasing the resistance of the mitochondrial membrane to noxious stimuli, since volatile anesthetics sigdicantly affect mitochondrial Ca2+ uptake and release,36 a key event in apoptosis. 28 Volatile anesthetics interfere with signal transduction pathways, but there are conflicting reports on their effect on Padrenergic signaling. Halothane has been reported to antagonize p-adrenergic responses by inhibiting adenylate cyclase activity in dog, rat, and mouse cardiomy~cytes.~~ Lynch38 reported a significant and frequency-dependent depression of halothane and isoflurane on the slow Ca2+ channel entry in isoproterenoltreated cardiomyocytes. Another study did not find antagonistic effects of halothane on adenylate cyclase activity produced by i~o p r o t e r e n o l .~~ Conversely, halothane-mediated disruption of the p-adrenoceptor-G, protein interaction was postulated to enhance p-adrenergic signaling in rat and human cardiomyocyte~.~~ However, the reported potentiation of p-adrenoceptor stimulation was only examined on a short-term basis and did not overcome the negative inotropic effects of halothane. The conflicting results may be also attributed to methodologic differences and species differences. Moreover, sympathoadrenergic regulation of cardiac Ca2+ channels by NE involves both pand a-adrenoceptors, and a-adrenergic activation may inhibit P-adrenergic-stimulated L-type Ca2+ channel currents.41 Although not specifically investigated in this study, volatile anesthetics may activate adenosine type 1 receptors, which attenuate catecholamine-induced increases in cyclic adenosine rnonopho~phate.~~ Finally, desensitization of cardiac P-adrenoceptors by volatile a n e~t h e t i c s~~ or as an adaptive mechanism due to continuous p-adrenergic stimulation may play an important role in the present study.
Under the experimental conditions used, cardiomyocytes were quiescent, and addition of NE did not restore contraction. It is therefore unlikely that the observed anti-apoptotic effect of volatile anesthetics is mediated by a decreased oxygen demand or an improved oxygen supply-to-demand ratio. Caution should be exerted in extrapolating these in vitro observations to in vivo models. Although most volatile anesthetics are known to decrease sympathetic nervous system activity,44 recent studies provide evidence that desflurane induces intramyocardial catecholamine release in rat ventricular papillary muscle. 45 It is possible that this effect may diminish the postulated anti-apoptotic properties of des-flurane. Nonetheless, it is tempting to speculate that some of the previously reported beneficial therapeutic effects15-17 of volatile anesthetics may be explained by their inhibition of the apoptotic death signaling in cardiomyocytes. Because the time course for apoptotic cell death is only a few hours, apoptosis may be an important mechanism for loss of viable cardiomyocytes and myocardial dysfunction in the immediate perioperative period. Further studies should evaluate whether other classes of anesthetics, including barbiturates, propofol, or opioids, exert similar anti-apoptotic effects or, indeed, potentiate apoptotic death signaling in cardiomyocytes.
In conclusion, the results of this study indicate that volatile anesthetics offer significant protection against apoptotic cell death stimulated by the p-adrenergic pathway. The presented experimental data also suggest that the anti-apoptotic effect of volatile anesthetics is governed by modlfying cellular Ca2+ homeostasis and by inhibiting activation of the cell death initiator caspase-9 in adult rat cardiomyocytes.
